MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Filter by vocabulary: issues (multisite):

MSF is convinced that the Ugandan government's focus should be on providing comprehensive, decentralized, and community-based care for TB. 

More >

Despite recent advances, there's still a need to make noise about "the silent disease."

More >

This document gives an overview of MSF activities related to the humanitarian crisis in Somalia and neighboring Kenya and Ethiopia. The data presented, though provisional, account for MSF’s medical activities and financial income and expenditures in this region, while the narrative illustrates how MSF as a medical aid organization responded to this evolving crisis. 

More >

MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.

More >

This special report details MSF’s approach to delivering quality emergency obstetric care to prevent maternal death.

More >

This update details MSF's recent activities in South Sudan, the world's newest nation.

More >

While international attention focuses on Myanmar, a health crisis in the country looms large. An estimated 85,000 people infected with HIV in Myanmar are not receiving lifesaving treatment. 

More >

"Lives in the Balance" outlines the dire situation for people affected by HIV and tuberculosis (TB) in Myanmar.

More >

"Dadaab: Back to Square One" takes stock of the current humanitarian situation in the world's largest refugee camp.

More >

Read MSF's submission to the US trade representative on the 2012 Special 301 review process, which affects accessibility of medicines and important diagnostic tools.

More >

Pages